Scarica l'app Stockscreener
91.75
3.15%
-2.945
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NFLX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$94.70
Aprire:
$94.31
Volume 24 ore:
29.28M
Relative Volume:
0.63
Capitalizzazione di mercato:
$387.36B
Reddito:
$45.27B
Utile/perdita netta:
$10.98B
Rapporto P/E:
36.31
EPS:
2.5272
Flusso di cassa netto:
$9.46B
1 W Prestazione:
-2.75%
1M Prestazione:
+19.11%
6M Prestazione:
-25.25%
1 anno Prestazione:
-4.41%
Intervallo 1D:
$90.78
$95.75
Intervallo di 1 settimana:
$90.78
$96.34
Portata 52W:
$75.01
$134.12
Netflix Inc Stock (NFLX) Company Profile
Nome
Netflix Inc
Settore
Industria
Telefono
408-540-3700
Indirizzo
121 ALBRIGHT WAY, LOS GATOS
Compare NFLX vs DIS, WBD, LYV, FOXA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NFLX
Netflix Inc
|
91.75 | 399.84B | 45.27B | 10.98B | 9.46B | 2.5272 |
|
DIS
Walt Disney Co
|
99.29 | 176.12B | 95.62B | 13.27B | 7.06B | 6.7872 |
|
WBD
Warner Bros Discovery Inc
|
27.53 | 67.86B | 37.32B | 749.00M | 3.09B | 0.2873 |
|
LYV
Live Nation Entertainment Inc
|
154.57 | 36.74B | 25.20B | 139.94M | 304.98M | -0.2348 |
|
FOXA
Fox Corporation
|
57.76 | 24.52B | 16.58B | 1.93B | 2.31B | 4.1552 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-18 | Ripresa | Citigroup | Buy |
| 2026-03-09 | Ripresa | Wells Fargo | Equal Weight |
| 2026-03-02 | Ripresa | Barclays | Equal Weight |
| 2026-03-02 | Ripresa | JP Morgan | Overweight |
| 2026-02-27 | Aggiornamento | Arete | Neutral → Buy |
| 2026-02-27 | Ripresa | Evercore ISI | Outperform |
| 2026-01-23 | Reiterato | Robert W. Baird | Outperform |
| 2026-01-21 | Reiterato | BMO Capital Markets | Outperform |
| 2026-01-21 | Reiterato | Canaccord Genuity | Buy |
| 2026-01-21 | Reiterato | Deutsche Bank | Hold |
| 2026-01-21 | Reiterato | Goldman | Neutral |
| 2026-01-21 | Reiterato | Guggenheim | Buy |
| 2026-01-21 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2026-01-21 | Reiterato | Morgan Stanley | Overweight |
| 2026-01-21 | Reiterato | Needham | Buy |
| 2026-01-21 | Reiterato | Oppenheimer | Outperform |
| 2026-01-21 | Reiterato | Piper Sandler | Overweight |
| 2026-01-21 | Reiterato | Pivotal Research Group | Hold |
| 2026-01-21 | Reiterato | Rosenblatt | Neutral |
| 2026-01-21 | Reiterato | Rothschild & Co Redburn | Buy |
| 2026-01-21 | Reiterato | TD Cowen | Buy |
| 2026-01-21 | Reiterato | UBS | Buy |
| 2026-01-21 | Reiterato | Wolfe Research | Outperform |
| 2026-01-12 | Iniziato | HSBC Securities | Buy |
| 2026-01-09 | Reiterato | Goldman | Neutral |
| 2025-12-08 | Downgrade | Pivotal Research Group | Buy → Hold |
| 2025-12-08 | Downgrade | Rosenblatt | Buy → Neutral |
| 2025-11-18 | Reiterato | Barclays | Equal Weight |
| 2025-10-31 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-07 | Aggiornamento | Seaport Research Partners | Neutral → Buy |
| 2025-09-17 | Aggiornamento | Loop Capital | Hold → Buy |
| 2025-07-10 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-07-07 | Downgrade | Seaport Research Partners | Buy → Neutral |
| 2025-07-02 | Reiterato | Canaccord Genuity | Buy |
| 2025-07-02 | Reiterato | Goldman | Neutral |
| 2025-06-20 | Reiterato | Pivotal Research Group | Buy |
| 2025-06-12 | Reiterato | Oppenheimer | Outperform |
| 2025-06-03 | Reiterato | Jefferies | Buy |
| 2025-05-30 | Reiterato | BofA Securities | Buy |
| 2025-05-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-04-21 | Reiterato | BMO Capital Markets | Outperform |
| 2025-04-21 | Reiterato | Barclays | Equal Weight |
| 2025-04-21 | Reiterato | Canaccord Genuity | Buy |
| 2025-04-21 | Reiterato | Guggenheim | Buy |
| 2025-04-21 | Reiterato | JP Morgan | Overweight |
| 2025-04-21 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-04-21 | Reiterato | MoffettNathanson | Buy |
| 2025-04-21 | Reiterato | Morgan Stanley | Overweight |
| 2025-04-21 | Reiterato | Oppenheimer | Outperform |
| 2025-04-21 | Reiterato | Piper Sandler | Overweight |
| 2025-04-21 | Reiterato | Pivotal Research Group | Buy |
| 2025-04-21 | Reiterato | Wells Fargo | Overweight |
| 2025-04-17 | Ripresa | Piper Sandler | Overweight |
| 2025-03-27 | Iniziato | FBN Securities | Outperform |
| 2025-03-17 | Aggiornamento | MoffettNathanson | Neutral → Buy |
| 2025-01-24 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-01-23 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-01-22 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2025-01-22 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2025-01-22 | Reiterato | Oppenheimer | Outperform |
| 2025-01-22 | Reiterato | Pivotal Research Group | Buy |
| 2025-01-22 | Aggiornamento | Rosenblatt | Neutral → Buy |
| 2025-01-22 | Aggiornamento | The Benchmark Company | Sell → Hold |
| 2025-01-16 | Aggiornamento | Seaport Research Partners | Neutral → Buy |
| 2025-01-15 | Reiterato | BMO Capital Markets | Outperform |
| 2025-01-15 | Reiterato | Oppenheimer | Outperform |
| 2025-01-08 | Reiterato | Goldman | Neutral |
| 2025-01-06 | Reiterato | Argus | Buy |
| 2025-01-03 | Reiterato | The Benchmark Company | Sell |
| 2024-12-19 | Reiterato | UBS | Buy |
| 2024-12-16 | Downgrade | Loop Capital | Buy → Hold |
| 2024-12-16 | Reiterato | Oppenheimer | Outperform |
| 2024-12-11 | Reiterato | JP Morgan | Overweight |
| 2024-11-20 | Reiterato | Pivotal Research Group | Buy |
| 2024-10-18 | Reiterato | Needham | Buy |
| 2024-10-18 | Reiterato | Oppenheimer | Outperform |
| 2024-10-18 | Reiterato | Pivotal Research Group | Buy |
| 2024-10-16 | Reiterato | Loop Capital | Buy |
| 2024-10-11 | Reiterato | Guggenheim | Buy |
| 2024-10-10 | Reiterato | Morgan Stanley | Overweight |
| 2024-10-10 | Reiterato | Oppenheimer | Outperform |
| 2024-10-07 | Downgrade | Barclays | Equal Weight → Underweight |
| 2024-10-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-10-01 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-09-05 | Iniziato | China Renaissance | Hold |
| 2024-08-30 | Reiterato | Pivotal Research Group | Buy |
| 2024-07-17 | Reiterato | Guggenheim | Buy |
| 2024-07-16 | Reiterato | The Benchmark Company | Sell |
| 2024-07-15 | Reiterato | BofA Securities | Buy |
| 2024-07-12 | Reiterato | JP Morgan | Overweight |
| 2024-07-10 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-07-09 | Reiterato | TD Cowen | Buy |
| 2024-07-02 | Reiterato | Argus | Buy |
| 2024-05-28 | Reiterato | Evercore ISI | Outperform |
| 2024-04-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-04-19 | Aggiornamento | Needham | Hold → Buy |
| 2024-04-19 | Reiterato | Pivotal Research Group | Buy |
| 2024-04-15 | Reiterato | Deutsche Bank | Hold |
| 2024-04-12 | Reiterato | Morgan Stanley | Overweight |
| 2024-04-12 | Reiterato | Piper Sandler | Neutral |
| 2024-04-05 | Reiterato | Pivotal Research Group | Buy |
| 2024-03-25 | Reiterato | Citigroup | Neutral |
| 2024-03-12 | Reiterato | Jefferies | Buy |
| 2024-03-11 | Reiterato | Oppenheimer | Outperform |
| 2024-01-30 | Downgrade | Seaport Research Partners | Buy → Neutral |
| 2024-01-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2024-01-24 | Reiterato | BMO Capital Markets | Outperform |
| 2024-01-24 | Reiterato | BofA Securities | Buy |
| 2024-01-24 | Reiterato | Canaccord Genuity | Buy |
| 2024-01-24 | Reiterato | Evercore ISI | Outperform |
| 2024-01-24 | Reiterato | Goldman | Neutral |
| 2024-01-24 | Reiterato | Guggenheim | Buy |
| 2024-01-24 | Reiterato | JP Morgan | Overweight |
| 2024-01-24 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-01-24 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2024-01-24 | Reiterato | Morgan Stanley | Overweight |
| 2024-01-24 | Reiterato | Oppenheimer | Outperform |
| 2024-01-24 | Reiterato | Piper Sandler | Neutral |
| 2024-01-24 | Reiterato | Pivotal Research Group | Buy |
| 2024-01-24 | Reiterato | Redburn Atlantic | Buy |
| 2024-01-24 | Reiterato | Robert W. Baird | Outperform |
| 2024-01-24 | Reiterato | TD Cowen | Outperform |
| 2024-01-24 | Reiterato | UBS | Buy |
| 2024-01-24 | Reiterato | Wells Fargo | Overweight |
| 2023-09-18 | Reiterato | Evercore ISI | Outperform |
| 2023-08-25 | Aggiornamento | Loop Capital | Hold → Buy |
| 2023-07-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-07-17 | Reiterato | Deutsche Bank | Buy |
| 2023-07-13 | Reiterato | JP Morgan | Overweight |
| 2023-07-12 | Reiterato | UBS | Buy |
| 2023-07-05 | Aggiornamento | Goldman | Sell → Neutral |
| 2023-06-29 | Reiterato | Citigroup | Buy |
| 2023-06-28 | Reiterato | Oppenheimer | Outperform |
| 2023-06-13 | Reiterato | BofA Securities | Buy |
| 2023-06-13 | Reiterato | Guggenheim | Buy |
| 2023-04-19 | Reiterato | Deutsche Bank | Buy |
| 2023-04-19 | Reiterato | JP Morgan | Overweight |
| 2023-04-19 | Reiterato | Jefferies | Buy |
| 2023-04-19 | Reiterato | Piper Sandler | Neutral |
| 2023-04-19 | Reiterato | Pivotal Research Group | Buy |
| 2023-04-19 | Reiterato | Rosenblatt | Neutral |
| 2023-04-19 | Aggiornamento | UBS | Neutral → Buy |
| 2023-04-11 | Ripresa | Robert W. Baird | Neutral |
| 2023-01-23 | Reiterato | Argus | Buy |
| 2023-01-20 | Reiterato | Canaccord Genuity | Buy |
| 2023-01-20 | Reiterato | Deutsche Bank | Buy |
| 2023-01-20 | Reiterato | Evercore ISI | Outperform |
| 2023-01-20 | Reiterato | Goldman | Sell |
| 2023-01-20 | Reiterato | Guggenheim | Buy |
| 2023-01-20 | Reiterato | Jefferies | Buy |
| 2023-01-20 | Reiterato | MoffettNathanson | Market Perform |
| 2023-01-20 | Reiterato | Oppenheimer | Outperform |
| 2023-01-20 | Reiterato | Piper Sandler | Neutral |
| 2023-01-20 | Reiterato | Pivotal Research Group | Buy |
| 2023-01-20 | Reiterato | Robert W. Baird | Neutral |
| 2023-01-20 | Reiterato | The Benchmark Company | Sell |
| 2023-01-20 | Reiterato | Wedbush | Outperform |
| 2023-01-20 | Reiterato | Wolfe Research | Outperform |
| 2023-01-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-01-04 | Iniziato | New Street | Neutral |
| 2022-12-29 | Aggiornamento | CFRA | Sell → Buy |
| 2022-12-14 | Reiterato | Jefferies | Hold |
| 2022-12-09 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-06-14 | Downgrade | The Benchmark Company | Hold → Sell |
| 2022-06-10 | Downgrade | Goldman | Neutral → Sell |
| 2022-05-16 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-04-21 | Downgrade | DZ Bank | Buy → Hold |
| 2022-04-21 | Downgrade | Edward Jones | Buy → Hold |
| 2022-04-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-04-20 | Downgrade | BofA Securities | Buy → Underperform |
| 2022-04-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-20 | Aggiornamento | Needham | Underperform → Hold |
| 2022-04-20 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Downgrade | Pivotal Research Group | Buy → Sell |
| 2022-04-20 | Downgrade | Stifel | Buy → Hold |
| 2022-04-20 | Downgrade | UBS | Buy → Neutral |
| 2022-04-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-19 | Iniziato | Rosenblatt | Neutral |
| 2022-03-09 | Aggiornamento | Wedbush | Underperform → Neutral |
| 2022-01-31 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Edward Jones | Hold → Buy |
| 2022-01-24 | Downgrade | Jefferies | Buy → Hold |
| 2022-01-21 | Reiterato | BMO Capital Markets | Outperform |
| 2022-01-21 | Reiterato | BofA Securities | Buy |
| 2022-01-21 | Reiterato | Canaccord Genuity | Buy |
| 2022-01-21 | Reiterato | Cowen | Outperform |
| 2022-01-21 | Reiterato | Deutsche Bank | Hold |
| 2022-01-21 | Reiterato | Goldman | Neutral |
| 2022-01-21 | Reiterato | Guggenheim | Buy |
| 2022-01-21 | Reiterato | JP Morgan | Overweight |
| 2022-01-21 | Reiterato | MoffettNathanson | Neutral |
| 2022-01-21 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| 2022-01-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-21 | Reiterato | Oppenheimer | Outperform |
| 2022-01-21 | Reiterato | Piper Sandler | Overweight |
| 2022-01-21 | Reiterato | Pivotal Research Group | Buy |
| 2022-01-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-01-21 | Reiterato | Stifel | Buy |
| 2022-01-21 | Aggiornamento | The Benchmark Company | Sell → Hold |
| 2022-01-21 | Downgrade | Truist | Buy → Hold |
| 2022-01-21 | Reiterato | UBS | Buy |
| 2022-01-21 | Reiterato | Wolfe Research | Outperform |
| 2021-12-15 | Reiterato | The Benchmark Company | Sell |
| 2021-10-20 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-10-20 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-09-29 | Reiterato | The Benchmark Company | Sell |
| 2021-09-13 | Iniziato | Goldman | Neutral |
| 2021-09-08 | Reiterato | JP Morgan | Overweight |
| 2021-09-07 | Reiterato | Atlantic Equities | Overweight |
| 2021-07-21 | Reiterato | Credit Suisse | Outperform |
| 2021-07-21 | Reiterato | Deutsche Bank | Buy |
| 2021-07-21 | Reiterato | JP Morgan | Overweight |
| 2021-07-21 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2021-07-21 | Reiterato | Stifel | Buy |
| 2021-06-25 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-06-25 | Iniziato | Edward Jones | Hold |
| 2021-05-19 | Ripresa | Jefferies | Buy |
| 2021-04-21 | Ripresa | Oppenheimer | Outperform |
| 2021-04-21 | Reiterato | Pivotal Research Group | Buy |
| 2021-04-21 | Aggiornamento | Stifel | Hold → Buy |
| 2021-04-06 | Ripresa | Evercore ISI | Outperform |
| 2021-04-01 | Iniziato | Piper Sandler | Overweight |
| 2021-03-25 | Reiterato | The Benchmark Company | Sell |
| 2021-03-23 | Aggiornamento | Argus | Hold → Buy |
| 2021-01-21 | Aggiornamento | DZ Bank | Hold → Buy |
| 2021-01-20 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-01-20 | Reiterato | Pivotal Research Group | Buy |
| 2021-01-20 | Reiterato | The Benchmark Company | Sell |
| 2021-01-20 | Aggiornamento | UBS | Neutral → Buy |
| 2021-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-10-21 | Reiterato | BMO Capital Markets | Outperform |
| 2020-10-21 | Reiterato | Bernstein | Outperform |
| 2020-10-21 | Reiterato | Jefferies | Buy |
| 2020-10-21 | Reiterato | Morgan Stanley | Overweight |
| 2020-10-21 | Reiterato | Oppenheimer | Outperform |
| 2020-10-21 | Reiterato | Piper Sandler | Overweight |
| 2020-10-21 | Reiterato | Pivotal Research Group | Buy |
| 2020-10-21 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-10-21 | Reiterato | The Benchmark Company | Sell |
| 2020-10-21 | Reiterato | Wedbush | Underperform |
| 2020-10-21 | Reiterato | Wells Fargo | Equal Weight |
| 2020-10-16 | Reiterato | Morgan Stanley | Overweight |
| 2020-10-15 | Reiterato | Canaccord Genuity | Buy |
| 2020-10-14 | Reiterato | Goldman | Buy |
| 2020-10-07 | Reiterato | Pivotal Research Group | Buy |
| 2020-09-28 | Reiterato | The Benchmark Company | Sell |
| 2020-09-15 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-09 | Ripresa | Raymond James | Mkt Perform |
| 2020-09-04 | Reiterato | The Benchmark Company | Sell |
| 2020-07-29 | Reiterato | Loop Capital | Buy |
Mostra tutto
Netflix Inc Borsa (NFLX) Ultime notizie
The Netflix Metamorphosis: From Streaming Pioneer to Diversified Media Giant (2026 Update) - FinancialContent
Mystery Inc. Cast Announced for Live Action “Scooby-Doo” Series at Netflix - news.newonnetflix.info
Jacobs & Co. CA Acquires 138,253 Shares of Netflix, Inc. $NFLX - MarketBeat
Scooby-Doo Live-Action Netflix Series Casts Shaggy, Velma, And Fred To Join McKenna Grace’s Daphne - empireonline.com
For 2026, Netflix is doubling down on original storytelling and comedies - Los Angeles Times
Casting News: Netflix's Scooby-Doo Rounds Out Mystery Inc., The Morning Show Adds Jesse Williams, And More - IMDb
Disney Investment Opportunity: Streaming Profits & Park Growth in 2026News and Statistics - IndexBox
Netflix Stock Today: NFLX Climbs on Citi Bullish Call as Streaming Leader Eyes Price Hikes & Buybacks - International Business Times Australia
Crashing 51%, 3 Reasons to Buy This Netflix Rival in March and Hold for 5 Years - The Motley Fool
Netflix, Inc. $NFLX is Alecta Tjanstepension Omsesidigt's 9th Largest Position - MarketBeat
Crashing 51%, 3 Reasons to Buy This Netflix Rival in March and Hold for 5 Years - The Motley Fool
Netflix’s Live-Action ‘Scooby-Doo’ Series Reveals Mystery Inc. Cast - Geek Culture
Matt Damon & Ben Affleck’s The Rip Claims Refuted by Netflix Execs - Yahoo
Coming soon to Netflix: ‘Everyone’s favorite movie’ - IMDb
Netflix’s Split Seasons May Have Peaked; Long Gaps Between Seasons May Be Here To Stay On Some Series: “Absence Makes The Heart Grow Fonder” - IMDb
Netflix unveils live-action 'Scooby-Doo' cast with Mckenna Grace - KCENTV.com
Jason Bateman to direct Netflix thriller ‘The Cackling Of The Dodos’ - IMDb
Prince Harry and Meghan Markle Still Have ‘a Relationship’ With Netflix Despite Fall Out Reports: ‘No Juicy Story There’ - IMDb
Netflix Execs Deny Mandated Plot Repeats for Distracted Viewers: ‘So Offensive’ - IMDb
Meghan vs. Netflix: Dueling reports detail what led to split - Yahoo
West Virginia on the big screen: 2 locally produced films featured on Netflix’s ‘Top 10 Movies in the U.S.’ - WDTV 5
The gang's all here: Netflix unveils more live-action ‘Scooby-Doo' series cast - NBC Los Angeles
Netflix’s Live Action ‘Scooby-Doo’ Unmasks the Members of Mystery Inc. - IMDb
Netflix’s ‘Scooby-Doo’ Live-Action Series Has Found Its Mystery Inc. Cast - Bloody Disgusting
Netflix Reportedly Planning 'KPop Demon Hunters' World Tour With Live Shows in 2027 - IMDb
Netflix Execs: No, We Don’t Tell Filmmakers to Repeat the Plot - IMDb
'Lord of the Flies' Series Sets Netflix Premiere Date, Reveals Cast & First Details - IMDb
‘Baby Reindeer,’ ‘Adolescence’… Netflix’s ‘Lord of the Flies’ adaptation is now coming for all the Emmys - IMDb
Netflix Execs ‘Laughed’ at Claim the Streamer Demands Movies and TV Shows Restate Plot Points for Viewers: ‘There’s No Such Principle’ - IMDb
Tiny Particles, Big Risk: Could Netflix’s New Documentary, The Plastic Detox, Accelerate Microplastic Litigation in the Cosmetic and Personal Care Product Industry? - The National Law Review
Bela Bajaria Responds to Report of Netflix Distancing Itself From Meghan Markle and Prince Harry - IMDb
Netflix's Age Of Attraction Couples, Ranked From Least To Most Delusional - IMDb
Prince Harry, Meghan Markle’s Netflix relationship under scrutiny - The Spokesman-Review
‘Emily in Paris’ Creator Darren Star, David Schulner Set Netflix Rom-Com Series ‘Uncorked’ - IMDb
Zoinks! “Scooby-Doo” live-action Netflix cast revealed - Yahoo
Mystery Inc. Is Back! The Cast of Netflix's Upcoming Live-Action Scooby-Doo Series Revealed! - HorrorFuel.com
Jason Bateman Directing Sam Rockwell and Woody Harrelson in Netflix’s ‘The Cackling of the Dodos’ - IMDb
Netflix Plans ‘KPop Demon Hunters’ Global Concert Tour - Bloomberg.com
Scooby-Doo Live-Action Netflix Show Announces Full Mystery Inc. Cast - ComingSoon.net
Mckenna Grace, Tanner Hagen, Abby Ryder Fortson, Maxwell Jenkins Cast In Netflix Live-Action Scooby-Doo Series - IMDb
“We Think They Do.” Netflix Stock (NASDAQ:NFLX) Notches Up on Several Growth Vectors - TipRanks
‘Scooby-Doo’ Live-Action Netflix Series Casts Maxwell Jenkins as Fred, Abby Ryder Fortson as Velma, Tanner Hagen as Shaggy - IMDb
La serie live-action de ‘Scooby-Doo’ de Netflix desenmascara a su reparto protagonista. - IMDb
Darren Star Rom-Com ‘Uncorked’ Lands Series Order at Netflix - IMDb
Netflix Cast Every Mystery Inc Member Except the One You’d Expect - Altitudes Magazine
Jason Bateman to Direct Sam Rockwell and Woody Harrelson in New Netflix Feature - IMDb
Netflix Snags Wine Country Rom-Com ‘Uncorked’ From Darren Star, David Schulner - IMDb
‘Lord of the Flies’ Series From ‘Adolescence’ Co-Creator Gets Netflix Release Date | Photos - IMDb
Netflix’s Live-Action SCOOBY-DOO Series Finds The Rest Of Its Mystery Inc. Gang - Fangoria
‘Scooby-Doo’ Live-Action Netflix Series Casts Casts Maxwell Jenkins as Fred, Abby Ryder Fortson as Velma, Tanner Hagen as Shaggy - IMDb
Netflix’s Live-Action ‘Scooby-Doo’ Finds Its Fred, Velma and Shaggy - IMDb
Netflix Inc Azioni (NFLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):